1 / 125

Solid Tumors Dr. H. Murat MUTUŞ

Solid Tumors Dr. H. Murat MUTUŞ. Wilms’ Tumor. Also called as Nephroblastoma One of the most common solid tumors of pediatric age group Seen in frequency of 8/10 6 under the age of 15 years Frequency varies according to geographical areas Age, Sex and Bilaterality:

kpowell
Download Presentation

Solid Tumors Dr. H. Murat MUTUŞ

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Solid Tumors Dr. H. Murat MUTUŞ

  2. Wilms’ Tumor • Also called as Nephroblastoma • One of the most common solid tumors of pediatric age group • Seen in frequency of 8/106 under the age of 15 years • Frequency varies according to geographical areas • Age, Sex and Bilaterality: • Male/Female ratio=1/1,1 • Mean age of admittance is around 3,5-4 years • Bilateral Wilms tumor is seen in 7% of cases

  3. Associated anomalies accompanying Wilms’ Tumor • Aniridia, • Hemihypertrophy • Undescended testis, • Hypospadias • Male pseudohermaphroditism • Renal hypoplasia • Renal ectopia • Duplication anomalies • Horseshoe kidney

  4. Syndromes accompanying Wilms’ Tumor • WAGR syndrome • Wilms’ Tumor, aniridi,a genitourinary malformations, mental retardation • Wiedemann- Beckwith syndrome (WBS) • Macroglossia, organomegaly, hemihypertrophy, abdominal wall defects, hypoglycemia, earbud deformities • Drash syndrome • Pseudohermaphrotidism, degenerative kidney diseases • Klippel-Trenaunay syndrome • Perlmann syndrome • Specific cytogenetic anomalies

  5. Wiedemann- Beckwith syndrome (WBS) • Macroglossia • Organomegaly • Hemihypertrophy • Abdominal wall defects • Hypoglycemia • Earbud deformities

  6. Wilms’ Tumor • Aniridia • 1000 times higher risk for development of Wilms’ Tumor • All children with aniridia should be physically examined and evaluated by abdominal ultrasound every 3 months in first 2 years, snd and every 6 months until 4 years of age • Hemihypertrophy: • 1000 times higher risk when compared with normal population • Such cases should be followed same as in aniridia

  7. Wilms’ Tumor • Genitourinary anomalies • While incidence of undescended testicle and hypospadias are 0,7% and 1,0% in normal population, in Wilms’ tumor cases this ratio is 5,2% • Incidence of bilateral tumors are higher in this group of patients with genitourinary anomalies (25%) • Familial Wilms’ tumor • Family history is 1.5% in Wilms tumor • Bilaterality is higher in familial cases (16%)

  8. Table. Rate of congenital anomalies and syndromes seen in Wilms’ tumor patients. NWTS group results between the years 1980 and 1999.

  9. Molecular Genetics: • Wilms’ tumor gene • WT-1 gene; a tumor supressor gene located in p13 arm of chromosome 11 (11p13). • This gene is deleted in all children with WAGR sendrome. In sporadic Wilms’ tumor patients, deletion is seen in 5-10 % of cases. • WT-2 gene (11p15) is also a supressor gene. • Other genetic anomalies are seen. • Eg: p53 supressor gene plays a role in aggressive form of Wilms’ tumor.

  10. Clinical findings / Symptoms • Abdominal mass • Generally first sign • Hypertension • Hematuria

  11. Clinical findings / Symptoms • A large, regular surfaced, smooth mass may be palpated • The lesion generally is not painful, and is relatively immobile • Generally does not cross the midline • Abdominal pain, fever, and anemia may occur • intraperitoneal or subcapsular bleeding is a result of tumor necrosis. Therefore, when this occurs, it is difficult to differentiate from Neuroblastoma • İntravenous involvement • cardiac murmur, hepatosplenomegaly, ascites, varikocele and gonadal metastasis • Generally metastasizes to lungs

  12. DIAGNOSIS / Imaging • Routinely; • Chest X-Ray • Abdominal plain graphy, followed by • USG and CT and/or MRI • Nature of the mass, and the organ of origin, • Contralateral renal parenchymal evaluation, • Presence of Bilateral disease, • Patency of VCI ve renal vein • Presence of distant metastasis.

  13. IVP

  14. USG

  15. CT

  16. Metastasis

  17. Blastomatozis Wilms

  18. Wilms + Adenopathy

  19. Wilms + Adenopathy + Capsular Invasion

  20. Bilateral Wilms’ Tumor -MRI

  21. Bilateral Wilms

  22. Bilateral Wilms

  23. Pathology • Composed of blastemal, stromal or epithelial elements. • Any cell type may be dominant, or there may be mixed tissue pattern • Histopathologically; “favorable or unfavorable histology” / The most important prognostic factor

  24. Pathology • Nephroblastomatosis (Nephrogenic rest) • accepted as a premalignant lesion • Histologically it is a persistant metanephric tissue • Has a clear relationship with Wilms’ tumor • They are found in 1% of postmortem autopsies of normal population, but seen as frequent as 25-40 % of Wilms’ tumor patients • They are the most important findings for increased risk of future contralateral Wilms’ tumor occurance

  25. Nephrogenic rest

  26. Wilms T-NWTS-5 Staging System • Stage I: Tumor limited to kidney and totally resectable – Renal capsule is intact • Stage II: Tumor extending beyond kidney, but still totally resectable • Stage III: Residual nonhematogenous tumor present, but limited to abdomen • Stage IV: There is hematogenous or lymph node metastasis extending beyond abdominopelvic area • Stage V: There is bilateral kidney involvement during diagnosis

  27. Stage 1 Tumor limited to kidney and totally resectable – Renal capsule is intact

  28. Stage 2 Tumor extending beyond kidney, but still totally resectable

  29. Stage 3 Residual nonhematogenous tumor present, but limited to abdomen

  30. Stage 4 There is hematogenous or lymph node metastasis extending beyond abdominopelvic area

  31. Stage 5 There is bilateral kidney involvement during diagnosis

  32. Surgical Treatment • 2 basicresponsibility of surgeonexists: • Complete resection of the WHOLE viabletumortissue, • Supplycorrectinformationrequiredforstaging Inmostcasesunilateralradicalnephroureterectomy is performed The presence of venousinvolvementorcontralateraldiseaseshould be evaluated, andifdiagnosed, specificsurgicalproceduresshould be done accordingly Continuedclinicalstudiesnamed “NationalWilms’ Tumor Study-1,2,3,4,5” developtreatmentmodalities of radiationandchemotherapy . Theseprotocolsareused as adjuvantstosurgicaltreatment.

  33. CLEAR CELL SARCOMA • Known as bone metastasizing renal tumor in children. They resemble to WT with UH. 25% of cases metastasize to bone. • Important histological features; fibrovascular septae formation in tumor with vascular arcus formation and division of tumor cells into chords or columns • Multicentric or bilateral clear cell sarcoma has not been reported • In treatment all patients undergo nephrectomy, radiotheraphy, and chemotheraphy as a standart approach. If bone metastasis present, long term survival is very low (16%)

  34. RHABDOID TUMORS • Rare but very fatal • They are thought to origin from neural crest cells of renal medulla • Consist of %2 of renal tumors • Hypercalcemia may be seen • Differential diagnosis from WT is possible by CT has been reported • All cases are unilateral • May metastasize to anywhere, but most frequently to lungs • Surgery, chemotherapy and radiotherapy are used for treatment, but results are not satisfactory

  35. RENAL ADENOCARCINOMA • They are very rare tumors in children. Most frequently seen in late childhood, or in adolescents. • In adult forms, the triad of abdominal pain, hematuria, and flank mass is classical; but in children and adolescents, this is not so common. • Metastasize to lungs, liver, and bone. Prognosis depends on clinicopathological stage. • Recommended treatment is; radical nephrectomy+regional lymphadenectomy. Expected survival rate is around 50%. Chemotherapy and radiotherapy may also be added to treatment.

  36. CONGENİTAL MESOBLASTİC NEPHROMA • Most common renal tumor in first 3 months of life • After 4. month, Wilms’ tumor is most common • 5% of all pediatric renal tumors • More than %90 are seen in 1st year of life • Twice more common in male children • Most common age of admittance is between 3-4 months of age

  37. CONGENİTAL MESOBLASTİC NEPHROMA • The most common presenting sign is a palpable mass in the abdomen • Hematuria may rarely be seen • May be diagnosed prenatally • Polihydramnios may be present • Preterm delivery, low birth weight, and hydrops faetalis may occur

  38. CONGENITAL MESOBLASTIC NEPHROMA • No Bilateral lesion reported • Treatment is surgical removal • %95 cure with surgery only, • %5 recurrence possible • USG follow up after surgical removal is necessary • Although this tumor has a relatively benign character, it may rarely act agresively

  39. CONGENITAL MESOBLASTIC NEPHROMA

  40. CONGENITAL MESOBLASTIC NEPHROMA

  41. CONGENITAL MESOBLASTIC NEPHROMA Longitudinal section of kidney showing large blood clot occupying upper and middle poles with thinned cortex

  42. CONGENİTAL MESOBLASTİC NEPHROMA Low-power photomicrograph showing cystic area, large fibrous strand, and innumerable small, round cells in renal cortex typical of mesoblastic nephroma

  43. Multicytistic nephroma

  44. Bilateral Multicystic Nephroma

  45. Leucemic Renal Involvement

More Related